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Objective/Background: Phagolysosome process in macrophage of leprosy patients’ is impor-
tant in the early phase of eliminating Mycobacterium leprae invasion. This study was to clar-
ify the involvement of Rab5, Rab7, and trytophan aspartate-containing coat protein (TACO)
from host macrophage and leprae lipoarabinomannan (Lep-LAM) and phenolic glycolipid-1
(PGL-1) from M. leprae cell wall as the reflection of phagolysosome process in relation to 16
subunit ribosomal RNA (16S rRNA) M. leprae as a marker of viability of M. leprae.
Methods: Using a cross sectional design study, skin biopsies were obtained from 47 newly
diagnosed, untreated leprosy at Dr Soetomo Hospital, Surabaya, Indonesia. RNA isolation
and complementary DNA synthesis were performed. Samples were divided into two
groups: 16S rRNA M. leprae- positive and 16S rRNA M. leprae-negative. The expressions of
Rab5, Rab7, TACO, Lep-LAM, and PGL-1 were assessed with an immunohistochemistry
technique.
Result: Using Mann-Whitney U analysis, a significant difference in the expression profile of
Rab5, Rab7, Lep-LAM, and PGL-1 was found (p < .05), but there was no significant difference
of TACO between the two groups (p > .05). Spearman analysis revealed that there was a sig-
nificant correlation between the score of Rab5, Rab7, Lep-LAM, and PGL-1 and the score of
16S rRNA M. leprae (p < .05).
156 I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 5 ( 2 0 1 6 ) 1 5 5 –1 6 3Conclusion: In M. leprae infection, Rab5, Rab7, and Lep-LAM play important roles in the fail-
ure of phagolysosome process via a membrane trafficking pathway, while PGL-1 plays a role
via blocking lysosomal activities. These inventions might be used for the development of
an early diagnostic device in the future.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
Leprosy is a chronic infection caused by Mycobacterium leprae
infection that may cause damage to skin tissues, nerves, eyes,
or systemic damage. If it continues, it may lead to disabilities
with the impact of reduced quality of life of the individuals
and society [1]. Indonesia is a country with the third highest
number of leprosy patients in the world after India and Brazil,
with the discovery of new cases increasing from year to year
[2]. The most important cause of the high incidence rate and
dominance of the multi-bacillary type of leprosy, which is
potentially infectious in Indonesia, is the high transmission
caused by the difficulty of early detection.
M. leprae cannot be cultured in an artificial medium, so the
study of the bacteria is often difficult. Viability of M. leprae
can be detected by morphological index of acid fast bacilli
using Ziehl Nielsen staining. This examination has low sensi-
tivity and specificity that affect the quality of viability detec-
tion. The detection of 16 subunit ribosomal RNA (16S rRNA)
of M. leprae using the method of reverse transcriptase-
polymerase chain reaction (RT-PCR) can be used as a marker
of viability of M. leprae [3]. The 16S rRNA will be destroyed
after M. leprae dies, thus the study of 16S rRNA using the
RT-PCR method can reflect the viability of M. leprae with high
sensitivity and specificity [4,5]. Although this method is rela-
tively expensive and requires special facilities and infrastruc-
ture, it is relatively easier to perform than radiorespirometric
methods [6–8].
When viable M. leprae in the body of an individual is pre-
sent, theoretically the individual’s phagocytic function has
failed. Phagocytic function failure can occur due to the failure
of the phagolysosomeprocess so thatM. leprae remains persis-
tent. Phagolysosome process failure should be identified early
because there are differences in the profiles of a variety of
compounds derived from M. leprae, as well as from the host
[9,10]. Based on the extrapolation of research that has been
done with other mycobacteria, some proteins are related to
the phagolysosome failure process and the most important
is Rab5 that has been shown to play a role in early endosome
fusion with the phagosome of Mycobacterium tuberculosis and
Mycobacterium bovis bacille Calmette–Guerin (BCG). Rab7 has
been shown to play a role in late endosome fusion with
Mycobacterium marinum phagosome and M. bovis BCG. Trypto-
phan aspartate-containing coat protein (TACO), has been
shown to play a role in resisting the movement of M. bovis
BCG phagolysosome. These three proteins are present in the
host’s macrophage cell membrane [11–13]. In addition, the cell
wall components of M. leprae, the leprae lipoarabinomannan
(Lep-LAM) and phenolic glycolipid-1 (PGL-1), are also thought
to inhibit the phagolysosome by extrapolating from theresearch performed on the cell wall of M. tuberculosis [14,15].
However, to date, there remains uncertainty in the expression
profile of Rab5, Rab7, TACO, Lep-LAM, and PGL-1 related to the
effectiveness of the phagolysosome process ofM. leprae infec-
tion as reflected by the viability of M. leprae.
Knowing the mechanisms of the host macrophage
response to M. leprae infection, particularly in the phagolyso-
some process, provides an opportunity to solve the problems
of early detection of M. leprae viability. It has been reported
that immunohistochemical examination has good prospects
for early detection of leprosy, especially in endemic countries,
with methods that can be done with simple laboratory equip-
ment [16]. The rationale of immunohistochemical examina-
tion for the detection of M. leprae viability originates from
facts showing that failed phagolysosome process causes M.
leprae persistence.
The purpose of this study was to elaborate Rab5, Rab7, and
TACO (host components) expression profiles and Lep-LAM
and PGL-1 (cell wall components of M. leprae) as a reflection
of the effectiveness processes of the phagolysosome associ-
ated with the presence or absence of 16S rRNA M. leprae as
the marker of M. leprae viability.
Materials and methods
This study was an observational cross-sectional analytic
study to prove that there are differences in the expression
profile of Rab5, Rab7, TACO, Lep-LAM, and PGL-1 in macro-
phages of new leprosy patients based on the presence or
absence of 16S rRNA M. leprae expression, as well as a corre-
lation between 16S rRNA of M. leprae expression with the
expression of Rab5, Rab7, TACO, Lep-LAM, and PGL-1 in new
leprosy patients’ macrophages.
The samples were taken from new leprosy patients over
3 months at the Dermatovenereology Clinic, Dr. Soetomo
Hospital, Surabaya, Indonesia, who met the sample inclusion
criteria. Leprosy diagnosis was made clinically and bacterio-
logically. The sample inclusion criteria were new leprosy
(diagnostic criteria of World Health Organization), aged 15–
40 years, and willing to join the study by signing an informed
consent.
Examination of the 16S rRNA of M. leprae with real time
PCR was performed to obtain more sensitive and specific
results of the examination compared with conventional PCR
[17]. To date, there have been no scientific publications on
the primer used in the examination of the 16S rRNA of M.
leprae with real time PCR. Therefore, the primer and probe
design were done using the Primer Express Software program:
Primer express software version 3.0 Applied Biosystems. At
the P2–P3 (69–239 bp) region there were 50 combinations of
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studying the GC content, melting temperature, and primer
dimer, the forward primers were chosen as follows: P2, F,
P24, and P25 and the reverse primers were P3, R, P34, and
P35 with the order as shown in Fig. 1. The sequences of the
primers are described in Table 1.
After that, forward and reverse primers were combined
according to Applied Biosystems 7300 Real Time PCR Machine
and an optimum primer length between 100 bp and 150 bp, so
the chosen pairs were P2–P3, P2–P34, and P2–P35, and a sensi-
tivity test was done using probes to increase specificity, with
the results as shown in Table 2.
Based on the results shown in Table 2, we used primers P2
(forward), P34 (reverse), and probe on the examination of 16S
rRNA M. leprae using real time PCR.
Sampling was done in the dressing room of the Derma-
tovenereology Laboratory, Dr. Soetomo Hospital. RT-PCR tests
were performed at the Leprosy Study Group, Institute of
Tropical Disease, Universitas Airlangga, Surabaya, Indonesia
and immunohistochemical examination was performed at
Gramik Laboratory, Faculty of Medicine, Universitas
Airlangga. The study was conducted from September 2006
to December 2006. Research proposal had been approved by
the Ethics Commission of the Dr. Soetomo Hospital (ethical
clearance number 59/Panke.KKE/2005).
Assessment of the expression of Rab5, Rab7, TACO,
Lep-LAM, and PGL-1 was done by a combination of analytical
calculation of the number of cells counted manually in 20
visual fields and image analysis method to calculate the
intensity of immunohistochemical staining using Nikon
Capture NX (Nikon Corporation, Minato, Tokyo, Japan) [18].
Data processing and analysis
A reliability test was done between two observers in counting
the number of macrophage cells expressing Rab5, Rab7,
TACO, Lep-LAM, and PGL-1. Score division to count the num-
ber of cells was based on quartiles and median. Score division
for staining intensity was based on the percentiles of 33% and
66%. The multiplication result was obtained from the score of
cells counted with the score for counting staining intensity in
each sample. Nonparametric two-sample comparison test on
the variables Rab5, Rab7, TACO, and PGL Lep-LAM-1 expres-
sion was based on the presence or absence of 16S rRNA of
M. leprae. Score division for the calculation of the quantity
of 16S rRNA of M. leprae was based on quartiles and median.
Nonparametric correlation test was done between the score
of 16S rRNA of M. leprae with a score of Rab5, Rab7, TACO,
Lep-LAM, and PGL-1.Fig. 1 – Forward and reverse prResults
There were 47 patients who met the criteria, consisting of 30
men (63.83%) and 17 women (36.17%). To determine the viabil-
ity ofM. leprae, this study examined 16S rRNA ofM. lepraewith
real time PCR using the primers P2 (forward), P34 (reverse),
and probe Taq man, with the results as shown in Fig. 2.
The amplification plot in Fig. 2 shows the number of cycles
when fluorescence began to be detected in each sample. Vary-
ing results were seen. Of the 47 samples, we obtained positive
results in 35 samples (74.47%) and negative results in 12 sam-
ples (25.53%).
Figs. 3–7 show the representative results of immunohisto-
chemical examination of skin biopsies to detect Rab5, TACO,
Lep-LAM, PGL-1, and Rab7 by monoclonal antibodies against
each protein.
Reliability test results demonstrated the suitability of the
macrophage cell counts expressing Rab5, Rab7, TACO, Lep-
LAM, and PGL-1 in both observers (p > .05). Combined score
was obtained by multiplying the score of the number of cells
expressing Rab5, Rab7, TACO, Lep-LAM, and PGL-1 with a
score of staining intensity of cells expressing Rab5, Rab7,
TACO, Lep-LAM, and PGL-1. Mann–Whitney U test was per-
formed to determine differences in the expression of Rab5,
Rab7, TACO, Lep-LAM, and PGL-1 based on the viability of
the positive and negative (Table 3).
In Table 3 it can be seen that the expressions of Rab5, Rab7,
LEP LAM, and PGL-1 in macrophages with positive viability of
macrophages were significantly different compared with
those with negative viability (p < .05), whereas TACO expres-
sion in macrophages with positive viability was not signifi-
cantly different compared with that in macrophages with
negative viability (p > .05).
Distribution of scores based on the quartiles was per-
formed from the results of calculations of 16S rRNA M. leprae
quantity by real time PCR. Furthermore, the correlation test
between the combined scores of cell numbers and staining
intensity with a score of quantity of 16S rRNA showed results
as in Table 4.
In Table 4 it can be seen that the expression of Rab5, Rab7,
Lep-LAM, and PGL-1 in macrophages has a correlation with
the quantity of 16S rRNA M. leprae as a marker of viability
(p < .05), whereas expression of TACO lacks correlation with
the quantity of 16S rRNA of M. leprae (p > .05).
Discussion
The phagolysosome process in macrophages was studied by
immunohistochemical assay to examine the expression ofimers and probes at P2–P3.
Table 1 – Design of primers and probes using primer express software program.
Name Position Location (bp) Sequence (50–30)
P2 Forward 69–91 CGG AAA GGT CTC TAA AAA ATC TT
F Forward 105–123 GAG TGG CGA ACG GGT GAG T
P24 Forward 142–161 CCT GCA CTT CAG GGA TAA GC
P25 Forward 150–169 TCA GGG ATA AGC TTG GGA AA
Probe 128–142 CGT GGG TAA TCT GC
P3 Reverse 218–239 CAT CCT GCA CCG CAA AAA GCT T
R Reverse 146–167 CAC TTC AGG GAT AAG CTT GGG A
P34 Reverse 185–204 ATG CGC CTT GAA GTC CTA TC
P35 Reverse 193–212 ACA AGA CAT GCG CCT TGA A
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Theoretically, the host’s proteins, Rab5, Rab7, and TACO, as
well as M. leprae’s proteins, Lep-LAM and PGL-1, play a role
in the phagolysosome process through membrane trafficking,
which is a material transfer event from one organelle to
another organelle during a series of phagolysosome processes
[19].
Our study revealed the significant differences in Rab5
expression between thepositive viability andnegative viability
groups (p = .002; Table 3), whereas Rab5 expression profile inTable 2 – The results of sensitivity tests of primer pairs P2–P3,
Primer pairs Basal pairs T
P2–P34 140 3
P2–P35 148 3
P2–P3 171 3
Fig. 2 – Reverse transcription-polymerase chain reaction amplifi
leprosy patients.the viable group was higher than that in the nonviable group.
Rab5 accumulation in the viable group indicates the occur-
rence of membrane trafficking inhibition that causes the fail-
ure of M. leprae ingestion by phagolysosome, in accordance
with phagolysosome studies on M. tuberculosis and M. bovis
BCG, inwhich Rab5 expression inmacrophages reveals phago-
some maturation failure [20]. Extrapolation was done by the
authors on the base of character similarities of bothmycobac-
teria. Spearman’s correlation test between the scores of 16S
rRNA ofM. leprae and Rab5 (p = .001; Table 4), further strength-P2–P34, and P2–P35.
hreshold cycle (CT) Minimal quantity (pg)
6.9 0.001
9.44 0.1
4.9 1
cation plot of 16 subunit ribosomal RNA in skin biopsies of
Fig. 3 – Expression of Rab5 in the skin biopsy section of sample number 14. (A) With the enlargement of 100; and (B) with the
enlargement of 450. Note. N = negative reaction (any colors other than brown); P = positive reaction (brown).
Fig. 4 – Expression of tryptophan aspartate-containing coat protein in the skin biopsy section of sample number 3. (A) With
enlargement of 100; and (B) with enlargement of 450. Note. N = negative reaction (any colors other than brown); P = positive
reaction (brown).
Fig. 5 – Expression of leprae lipoarabinomannan in the skin biopsy section of sample number 8. (A) With a magnification of
100; and (B) with a magnification of 450. Note. N = negative reaction (any colors other than brown); P = positive reaction
(brown).
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responsible for phagolysosome failure due to a significant cor-
relation between the expression of Rab5with the expression of
16S rRNA ofM. leprae as a marker ofM. leprae viability.
In this study, using the Mann–Whitney U test, we also
found significant differences in Rab7 expression betweenthe viable and nonviable group (p < .001; Table 3), where the
profile of Rab7 expression in the viable group was higher than
that in the nonviable group. The presence of Rab7 expression
in macrophages containing living bacteria where there was
phagolysosome failure denied the theory that the failure of
phagosome maturation continuing in the phagolysosome
Fig. 7 – Expression of Rab7 in the skin biopsy section of sample number 6. (A) With enlargement of 100; and (B) with
enlargement of 450. Note. N = negative reaction (any colors other than brown); P = positive reaction (brown).
Fig. 6 – Expression of phenolic glycolipid-1 in the skin biopsy section of sample number 16. (A) With the enlargement of 100;
and (B) with the enlargement of 450. Note. N = negative reaction (any colors other than brown); P = positive reaction (brown).
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assumed that there are Rab7 receptors in the phagosome,
not only in the late endosome. Phagolysosome studies in
other intracellular bacteria, Legionella pneumophila and M.
tuberculosis, showed confirming results in which there was
Rab7 expression on macrophages that contained viable bacte-
ria and no Rab7 expression in macrophages containing dead
bacteria. Similar properties of M. leprae with M. tuberculosis
were also shown in studies on the phagolysosome inM. tuber-
culosis where the macrophages with viable bacteria exhibited
Rab5 and Rab7 expression [21–23]. In addition, in studies
using latex bead, with the provision of phosphoinositideTable 3 – Mann–Whitney U test results of the differences in
the expression of Rab5, Rab7, tryptophan aspartate-con-
taining coat protein (TACO), leprae lipoarabinomannan
(Lep-LAM), and phenolic glycolipid-1 (PGL-1) based on
positive and negative viability with p = .05.
Variables p
Rab5 .002
Rab7 <.001
TACO .584
Lep-LAM <.001
PGL-1 <.0013-kinase (PI3K) inhibitor wortmannin which inhibits the
phagolysosome process, the accumulation of Rab7 was found
in macrophages, while the successful phagolysosome did not
show the expression of Rab7 [11]. This suggests the possibility
of an independent PI3K pathway to the success of the
phagolysosome process. Spearman’s correlation test between
the scores of 16S rRNA of M. leprae and Rab7 (p < .001; Table 4)
supports the fact that Rab7 expression correlated significantly
with the expression of 16S rRNA ofM. leprae as a marker ofM.
leprae viability. This study suggests that in M. leprae infection
where phagolysosome failure is characterized by high Rab5Table 4 – Spearman correlation test between combined
scores between cell number and staining intensity of the
expression of Rab5, Rab7, tryptophan aspartate-containing
coat protein (TACO), leprae lipoarabinomannan (Lep-LAM),
and phenolic glycolipid-1 (PGL-1) with the score of 16
subunit ribosomal RNA M. leprae quantity (p = .05).
Variables Correlation coefficient p
Rab5 0.483 .001
Rab7 0.682 <.001
TACO 0.065 .662
Lep-LAM 0.608 <.001
PGL-1 0.491 <.001
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used as markers of M. leprae viability.
LAM in mycobacteria has the ability to bind phosphatidyli-
nositol to the cellwall and is located at the surface ofmycobac-
teria. LAM also has an ideal position for initial interaction
between mycobacteria and macrophages [13,24]. Lep-LAM,
derived from M. leprae, has a structure similar to that in
mannosylated-LAM (Man-LAM), so it is thought to have the
ability to inhibit the bactericidal process by macrophages and
allows extrapolation of the Man-LAM role in phagolysosome
fusion failure. Although Lep-LAM contains fewer mannoses
than Man-LAM, Lep-LAM is found in greater numbers in M.
leprae compared with the number of Man-LAM inM. tuberculo-
sis. This causes Lep-LAM to remain virulent particularly in the
inhibition of phagolysosome fusion, resulting inM. leprae per-
sistence inmacrophages [14]. In this study, theMann–Whitney
U test found significant differences in Lep-LAM expression
between the viable and nonviable groups (p < .001), where the
Lep-LAM expression on macrophages in the viable group was
higher than that in nonviable group (Table 3). Lep-LAM accu-
mulation inmacrophageswith positive viability demonstrates
the role of Lep-LAM through the membrane trafficking barrier
that occurs due to the inhibition of Ca2+ increase. Additionally,
Lep-LAM is thought to have properties similar to Man-LAM
that can inhibit the Ca2+ channel in the endoplasmic reticulum
that would cause phagolysosome failure. Spearman’s correla-
tion test between 16S rRNA M. leprae scores and Lep-LAM
(p < .001; Table 4), reinforces the fact that the expression of
Lep-LAM has a significant correlation with the expression of
16S rRNA of M. leprae as a marker of M. leprae viability. Thus,
the expression profile of Lep-LAM in M. leprae infection can
be used as a viability marker, based on the role of membrane
trafficking where there has been an inhibition of increased
Ca2+ required to destroy germs.
PGL-1, a cell wall component of M. leprae, is associated
with the ability of this bacterium to survive. In theM. tubercu-
losis phagolysosome process, PGL is hypervirulent [25]. Inhibi-
tion of the phagolysosome process by PGL-1 in M. leprae is
suspected to occur through the inhibition of the lysosomal
activation process pathway [26]. In this study, we revealed sig-
nificant differences in PGL-1 expression between the viable
and nonviable group (p < .001), whereas PGL-1 expression in
the viable group is higher than that in the nonviable group
(Table 3). This proves that the lysosomal activation pathway
barriers play a role in the failure of the phagolysosome infect-
ing M. leprae. Spearman’s correlation test between 16S rRNA
scores of M. leprae and PGL-1 (p < .001; Table 4) further
strengthens the role of PGL-1 through a pathway that is
responsible for phagolysosome failure because there is a cor-
relation between the mean PGL-1 expression with the expres-
sion of 16S rRNA of M. leprae as a marker of viability. The
research was supported by a study conducted by Cho et al.
[27], who carried out an evaluation after treatment was given.
They found a significant reduction of PGL-1 antigen in blood.
In addition, research by Ramasesh et al. [28] also showed that
only viable M. leprae could produce PGL-1 where there was no
PGL-1 biosynthesis in uninfected macrophages. PGL-1 was
thought to directly inhibit proteolytic enzymes in the lyso-
somes, causing M. leprae to survive. However, another study
conducted by Hashimoto et al. [12] led to the conclusion thatPGL-1 did not show any correlation with the viability of M.
leprae as PGL-1 could still be found in the patient’s body,
although many had been damaged [12]. The remaining pres-
ence of PGL-1 in the skin tissue of leprosy patients who had
received treatment was because of the possibility that PGL-1
molecules could not be immediately degraded, although the
bacteria were dead. The results of this study showed that
the profile of PGL-1 expression in M. leprae infection could
be used as a marker of viability.
TACO is a protein that is bound by actin forming microfil-
ament structures that function for the movement and distri-
bution of organelles, including phagosome maturation in the
phagolysosome process of shrinkage (ruffling), chemotaxis,
and phagocytosis. TACO facilitates intracellular infection by
inhibiting the formation of actin so that the movement of
bacteria-containing phagosomes and the occurrence of
fusion with other intracellular vesicles becomes disrupted
[20,29]. In this study, a Mann–Whitney U test found no signif-
icant difference in TACO expression between the positive via-
bility group and the negative viability group (p = .584; Table 3).
Spearman’s correlation test between 16S rRNA of M. leprae
scoreswith TACO (p = .662) also showed no significant correla-
tion (Table 4). Thus, TACO, through the inhibition of
phagolysosome fusion pathway (ruffling), does not play a role
in the failure of M. leprae phagolysosome. It is not in accor-
dance with a phagolysosome study conducted in M. bovis
BCG where there is TACO accumulation in the phagosome
membrane that acts as a barrier to phagolysosome fusion,
thereby increasing the survival of germs. In the study with
other intracellular bacteria, namely Helicobacter pylori, there
is indication of phagolysosome fusion interruptions caused
by the retention of TACO [11]. In this study, TACO retention
of successful phagolysosomes can be caused by the presence
of a compound that accumulates in macrophages and influ-
ences TACO retention. A study in Japan also showed that
the accumulation of TACO in phagosome membranes was
not associatedwith the presence or absence of viableM. leprae
in macrophages [30]. In an in vitro study conducted by Suzuki
et al. [30], macrophages found with a negative smear exami-
nation showed TACO expression with moderate to vigorous
quality. The fact from Suzuki et al.’s study [30] can lead to
an assumption that TACO is not only retained by viable M.
leprae, but also by deadM. leprae. In addition, macrophage cul-
tures introduced with M. leprae showed no TACO expression,
so it can also be interpreted that TACO is not likely to be
involved in the mechanism of bacterial killing. Similarly, the
amount of lipid that fills the phagosome causes M. leprae to
float, so contact between TACO with M. leprae is reduced.
The unlikely role of TACO in phagolysosome process failure
was also indicated in in vivo studies by Suzuki et al. [30] in
which the macrophages derived from skin biopsies of
patients with lepromatous leprosy and tuberculoid type
showed that TACO expressions were not significantly differ-
ent. The above explanation indicates TACO has no role in
phagolysosome failure of M. leprae infection. In other words,
other phagocytic pathways that play a role in phagocytosis
process of M. leprae and TACO expression profiles cannot be
used as a marker of M. leprae viability.
In this study it can be assumed that the phagolysosome
process of M. leprae infection can also be carried out through
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expression in phagolysosome fails, there is a possible pres-
ence of a Rab7 receptor in the phagosome. The presence of
Lep-LAM can inhibit these pathways, thereby causing Rab7
to accumulate permanently in the macrophages. This sug-
gests that the PI3K-dependent pathway is not the only alter-
native for the M. leprae phagolysosome process. The
possibility that the PI3K pathway is independent in this
phagolysosome has been proven by studies conducted by
Vieire et al. [11], while the presence of Rab7 receptor in phago-
some has been demonstrated by Clemens et al. [23]. The inhi-
bition of the phagolysosome process by PGL-1 in M. leprae is
suspected to run through the inhibition of lysosomal activa-
tion pathway. The process is in line with some research that
has been conducted on M. tuberculosis. TACO does not play a
role in the failure of the phagolysosome in M. leprae infection.
In other words, other phagocytic pathways that play a role in
the process of phagocytosis of M. leprae and TACO expression
profiles cannot be used as markers of M. leprae viability.
An important finding as the result of this study is the role
of membrane trafficking in phagolysosome failure, which is
represented by two compounds derived from the host (Rab5
and Rab7) and from the agent (Lep-LAM). In addition, we
found the role of PGL-1 in the inhibition of lysosomes activa-
tion pathway in phagolysosome failure. Therefore, the
expression profiles of Rab5, Rab7, Lep-LAM, and PGL-1 can
be used as markers of M. leprae viability. From these findings,
an early diagnostic tool for leprosy based on expression pro-
files of Rab5, Rab7, Lep-LAM, and PGL-1 can be developed.
Early diagnosis of leprosy is a strong rationale for early ther-
apeutic intervention, so as to prevent the occurrence of dis-
ability or transmission. In addition to the above findings, it
is important to study the expression profiles of Rab5, Rab7,
Lep-LAM, and PGL-1 in peripheral blood mononuclear cells
(PBMCs). Based on the results of research conducted by the
Leprosy Study Group, Institute of Tropical Disease, Universi-
tas Airlangga [31], the results obtained no significant differ-
ences between expression profiles of 16S rRNA of M. leprae
in skin biopsy tissue and PBMCs using real time PCR. There-
fore, this study can be used as a base to explore the expres-
sion profiles of Rab5, Rab7, Lep-LAM, and PGL-1 in PBMCs,
which means that blood tests without skin biopsy are suffi-
cient to create a simplified and noninvasive early diagnostic
marker device for leprosy viability.
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